IntroductionNatural killer (NK) cells contribute to innate immune responses against virally infected and neoplastic cells. 1 NK cells usually recognize and attack tumor cells that lack major histocompatibility complex (MHC) class I. 2 Our previous studies in murine tumor models clearly demonstrated that gamma delta (␥␦) T lymphocytes play an important role in the regulation of antitumor NK-cell function. 3 Specifically, we have shown that ␥␦ T lymphocytes are required for the antitumor activity of NK cells in vivo. More recently, we have demonstrated that culturing human peripheral blood mononuclear cells (PBMCs) with agents that activate ␥␦ T lymphocytes induce NK cell-mediated cytotoxicity against tumors that normally resist NK killing. 4 These findings are concordant with other studies that show that ␥␦ T lymphocytes regulate the early phase of NK cell-mediated antibacterial responses in mice. 5 Taken in concert these data strongly suggest that ␥␦ T lymphocytes are important in the regulation of NK-cell functions.␥␦ T cells are characterized by the expression of a T-cell receptor (TCR) consisting of both gamma and delta chains, 6 and account for 1% to 10% of CD3 ϩ cells in the peripheral blood of healthy adults. 7 Approximately 70% of ␥␦ T lymphocytes express the V␥2V␦2 TCR and can be expanded and activated by phosphoantigens such as the cholesterol biosynthesis intermediate, isopentenylpyrophosphate (IPP), or synthetic bisphosphonates (eg, pamidronate disodium and zoledronic acid). [8][9][10] Upon stimulation, ␥␦ T lymphocytes acquire the capacity to destroy solid tumors of diverse origins such as squamous cell carcinoma of the head and neck (SCCHN), melanoma, colon cancer, and breast carcinoma, 4,[11][12][13] suggesting that ␥␦ T lymphocytes are important antitumor effector cells. The validity of this antitumor function is further supported by mouse models demonstrating that mice deficient in ␥␦ T cells have increased sensitivity to the development of methylcholanthrene (MCA)-induced tumors. 14 In addition, a recent pilot clinical study showed that ␥␦ T lymphocyte adoptive therapy for patients with advanced renal cell carcinoma was well tolerated and induced antitumor immune responses. 15 The antitumor effects of ␥␦ T lymphocytes are recognized to result from both direct killing of tumor targets and trans-activation of adaptive immune responses. For example, recent data demonstrate that activated ␥␦ T lymphocytes cause the maturation of dendritic cells that promote development of acquired immunity. 16 In addition, ␥␦ T cells are known to cross-present tumor antigens (Ags) to CD8 ϩ cytolytic T lymphocytes. 17,18 Despite their wellcharacterized role in mediating adaptive immune responses, the mechanisms by which ␥␦ T cells regulate cells of the innate immune system, such as NK cells, are unclear.In this report we demonstrate that ␥␦ T lymphocytes provide a costimulatory function for NK cells stimulated with suboptimal doses of immobilized human immuglobulin G1 (hIgG1). Costimulated NK cells display up-regulat...